Facilitating connection and multidisciplinary collaboration
Without a collective effort, research on neurodegenerative diseases will stall. EPND brings together leaders from academic research, the pharmaceutical industry, and data science in a multidisciplinary, public-private partnership for a diverse community in Europe and beyond. We will accelerate collective efforts by building on existing initiatives, removing traditional barriers to collaboration and discovery, and integrating research cohorts to make them discoverable, enabling information, sample, and data exchange.
Establishing a data- and sample-sharing platform
EPND will bring together existing cohorts and initiatives from public and private sectors to build a scalable and sustainable platform with a central point of access for data sharing, discovery, and analysis that utilises features, tools, and analytics provided by the Alzheimer's Disease Data Initiative’s (ADDI) AD Workbench.
Accelerating biomarker discovery through large-scale analysis and innovation
Large-scale biomarker research holds the key to developing more accurate diagnostics for neurodegenerative diseases. Learnings and data generated from biomarker case studies will be incorporated back into the EPND platform to drive continued innovation, enabling researchers to discover data and samples to answer new research questions.
Building long-term sustainability of infrastructure and processes
In establishing the EPND platform, we will provide governance, good practice, and guidance for users from across disciplines, validate and fine-tune functionality of the platform with case studies, and embed a sustainability-by-design approach to ensure a cost-effective, value-added platform for the global research community.
